Physician profile
Douglas James Olson
NPI 1417581117
$1,887.18
in general payments reported to CMS, 2019-2025
14 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $290 · 2024: $1,314 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $924 · Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $923.60 |
| Food and Beverage | $822.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,257.82 | 2024 | Stratafix, Attune |
| Depuy Synthes Sales INC. | $237.55 | 2022-2024 | Velys, Actis, Kincise |
| Vertex Pharmaceuticals Incorporated | $54.89 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $53.43 | 2022 | |
| Davol INC. | $45.68 | 2023 | Arista Ah Flexitip |
| Molnlycke Health Care US, LLC | $44.26 | 2023-2024 | Avance, Mepilex Border Post-Op Ag |
| Orthofix Medical, INC. | $34.72 | 2023-2025 | Physio-Stim |
| Ethicon US, LLC | $28.74 | 2022 | |
| Sanara Medtech INC. | $27.69 | 2025 | Celleraterx |
| Solventum Corporation | $26.04 | 2025 | Prevena |
| Amgen INC. | $21.63 | 2024 | Krystexxa |
| Curonix LLC | $19.89 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medwest Associates | $19.04 | 2023 | |
| Next Science LLC | $15.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.